However, metformin, aspirin and resveratrol have been extensively tested in vivo and in human studies including pregnancy, whereas FKBPL-based therapeutic peptides (AD-01 and ALM201) have only been tested in the context of cancer (El Helali et al., 2022). The gene discussed is FKBPL; the disease is cancer.